Health Canada — Medical Devices · Canada · 2017-09-26 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: The concentration of antibiotic in CAZ10 ceftazidime, CT1629B (lots listed above) may decrease over shelf life if not stored frozen. Specifically, antibiotic degradation has been identified in product stored at 8˚ between 2 and 3 years of shelf life.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.